![Michael Graves](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael Graves formerly worked at ViCentra BV, as Chief Executive Officer from 2014 to 2019, Coloplast A, as Principal, Unomedical A, as Principal, Novo Nordisk, Inc., as Principal, and Cellnovo Group SA, as Vice President-Manufacturing.
Ehemalige bekannte Positionen von Michael Graves
| Unternehmen | Position | Ende |
|---|---|---|
ViCentra BV
 ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Vorstandsvorsitzender | 20.05.2019 |
Unomedical A/S
 Unomedical A/S Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Corporate Officer/Principal | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
| COLOPLAST A/S | Corporate Officer/Principal | - |
| CELLNOVO | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Coloplast A/S
 Coloplast A/S Medical SpecialtiesHealth Technology Manufactures, supplies and markets medical and health care products. | Health Technology |
Unomedical A/S
Unomedical A/S Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
ViCentra BV
ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Health Technology |
